Comprehensive cervical cytology detection system for screening intraepithelial neoplasia. Combines immunochemical techniques with molecular markers for cervical disease identification. Designed for routine gynecological screening applications.
Manufactured by
Attogen Biomedical(Suzhou)Ltd.Inc
China
Attogen Biomedical (Suzhou) Ltd. is a National High-tech Enterprise focused on women's health diagnostics. The company developed China's first cervical cancer-specific protein biomarker detection kits, AI-powered automated medical detection equipment, and related diagnostic software. Founded by Dr. Chang Xiaojia, trained under Nobel laureates at Rockefeller University. ISO13485 certified with over 30 patents.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Atila BioSystems
United States · 1 relevant product
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
APPOLON BIOTECK SAS
France · 1 relevant product
26 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 43 closest product alternatives
Atila BioSystems · United States
A molecular assay designed for cervical cancer screening applications utilizing Atila BioSystems nucleic acid amplification chemistry.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for detecting and genotyping high-risk human papillomavirus strains. Supports cervical cancer screening and risk stratification.
APPOLON BIOTECK SAS · France
A molecular diagnostic test kit for HPV screening recommended by the CNR Papillomavirus for cervical cancer detection. The test has been validated through rigorous clinical studies demonstrating sensitivity, specificity, and compliance with international standards.
40 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products